Mu, X. et al. An origin of the immunogenicity of in vitro transcribed RNA. Nucleic Acids Res. 46, 5239–5249 (2018).
Mu, X. & Hur, S. Immunogenicity of in vitro-transcribed RNA. Acc. Chem. Res. 54, 4012–4023 (2021).
Baiersdörfer, M. et al. A facile method for the removal of dsRNA contaminant from in vitro-transcribed mRNA. Mol. Ther. Nucleic Acids 15, 26–35 (2019).
Moradian, H. et al. Chemical modification of uridine modulates mRNA-mediated proinflammatory and antiviral response in primary human macrophages. Mol. Ther. Nucleic Acids 27, 854–869 (2022).
Cottrell, K. A. et al. The competitive landscape of the dsRNA world. Mol. Cell 84, 107–119 (2024).
Pindel, A. & Sadler, A. The role of protein kinase R in the interferon response. J. Interferon Cytokine Res. 31, 59–70 (2011).
Kim, M. et al. Exogenous RNA surveillance by proton-sensing TRIM25. Science 388, eads4539 (2025).
Bérouti, M. et al. Pseudouridine RNA avoids immune detection through impaired endolysosomal processing and TLR engagement. Cell 188, 4880–4895 (2025).
Park, J. et al. Short poly(A) tails are protected from deadenylation by the LARP1–PABP complex. Nat. Struct. Mol. Biol. 30, 330–338 (2023).
Eisen, T. J. et al. The dynamics of cytoplasmic mRNA metabolism. Mol. Cell 77, 786–799 (2020).
Lim, J. et al. Uridylation by TUT4 and TUT7 marks mRNA for degradation. Cell 159, 1365–1376 (2014).
Norbury, C. J. Cytoplasmic RNA: a case of the tail wagging the dog. Nat. Rev. Mol. Cell Biol. 14, 643–653 (2013).
Decker, C. J. & Parker, R. A turnover pathway for both stable and unstable mRNAs in yeast: evidence for a requirement for deadenylation. Genes Dev. 7, 1632–1643 (1993).
Passmore, L. A. & Coller, J. Roles of mRNA poly(A) tails in regulation of eukaryotic gene expression. Nat. Rev. Mol. Cell Biol. 23, 93–106 (2022).
Yu, S. & Kim, V. N. A tale of non-canonical tails: gene regulation by post-transcriptional RNA tailing. Nat. Rev. Mol. Cell Biol. 21, 542–556 (2020).
Warkocki, Z., Liudkovska, V., Gewartowska, O., Mroczek, S. & Dziembowski, A. Terminal nucleotidyl transferases (TENTs) in mammalian RNA metabolism. Philos. Trans. R. Soc. Lond. B Biol. Sci. 373, 20180162 (2018).
Lim, J. et al. Mixed tailing by TENT4A and TENT4B shields mRNA from rapid deadenylation. Science 361, 701–704 (2018).
Kim, D. et al. Viral hijacking of the TENT4–ZCCHC14 complex protects viral RNAs via mixed tailing. Nat. Struct. Mol. Biol. 27, 581–588 (2020).
Seo, J. J. et al. Functional viromic screens uncover regulatory RNA elements. Cell 186, 3291–3306 (2023).
Li, Y. et al. The ZCCHC14/TENT4 complex is required for hepatitis A virus RNA synthesis. Proc. Natl Acad. Sci. USA 119, e2204511119 (2022).
Mueller, H. et al. PAPD5/7 are host factors that are required for Hepatitis B virus RNA stabilization. Hepatology 69, 1398–1411 (2019).
Wesselhoeft, R. A., Kowalski, P. S. & Anderson, D. G. Engineering circular RNA for potent and stable translation in eukaryotic cells. Nat. Commun. 9, 2629 (2018).
Geall, A. J. et al. Nonviral delivery of self-amplifying RNA vaccines. Proc. Natl Acad. Sci. USA 109, 14604–14609 (2012).
Koch, A. et al. Quantifying the dynamics of IRES and cap translation with single-molecule resolution in live cells. Nat. Struct. Mol. Biol. 27, 1095–1104 (2020).
Bloom, K., van den Berg, F. & Arbuthnot, P. Self-amplifying RNA vaccines for infectious diseases. Gene Ther. 28, 117–129 (2021).
Chen, H. et al. Branched chemically modified poly(A) tails enhance the translation capacity of mRNA. Nat. Biotechnol. 43, 194–203 (2025).
Chen, H. et al. Chemical and topological design of multicapped mRNA and capped circular RNA to augment translation. Nat. Biotechnol. 43, 1128–1143 (2025).
Fukuchi, K. et al. Internal cap-initiated translation for efficient protein production from circular mRNA. Nat. Biotechnol. https://doi.org/10.1038/s41587-025-02561-8 (2025).
Aditham, A. et al. Chemically modified mocRNAs for highly efficient protein expression in mammalian cells. ACS Chem. Biol. 17, 3352–3366 (2022).
Anhäuser, L. et al. Multiple covalent fluorescence labeling of eukaryotic mRNA at the poly(A) tail enhances translation and can be performed in living cells. Nucleic Acids Res. 47, e42 (2019).
Strzelecka, D. et al. Phosphodiester modifications in mRNA poly(A) tail prevent deadenylation without compromising protein expression. RNA 26, 1815–1837 (2020).
Orlandini von Niessen, A. G. et al. Improving mRNA-based therapeutic gene delivery by expression-augmenting 3′ UTRs identified by cellular library screening. Mol. Ther. 27, 824–836 (2019).
Leppek, K. et al. Combinatorial optimization of mRNA structure, stability, and translation for RNA-based therapeutics. Nat. Commun. 13, 1536 (2022).
Karikó, K. et al. Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Mol. Ther. 16, 1833–1840 (2008).
Agarwal, V. & Kelley, D. R. The genetic and biochemical determinants of mRNA degradation rates in mammals. Genome Biol. 23, 245 (2022).
Wang, X. et al. Detection and characterization of a 3′ untranslated region ribonucleoprotein complex associated with human α-globin mRNA stability. Mol. Cell. Biol. 15, 1769–1777 (1995).
Durrant, M. G. et al. Systematic discovery of recombinases for efficient integration of large DNA sequences into the human genome. Nat. Biotechnol. 41, 488–499 (2023).
Sahin, U. et al. BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans. Nature 595, 572–577 (2021).
Wayment-Steele, H. K. et al. RNA secondary structure packages evaluated and improved by high-throughput experiments. Nat. Methods 19, 1234–1242 (2022).
Hyrina, A. et al. A genome-wide CRISPR screen identifies ZCCHC14 as a host factor required for hepatitis B surface antigen production. Cell Rep. 29, 2970–2978 (2019).
Mueller, H. et al. A novel orally available small molecule that inhibits Hepatitis B virus expression. J. Hepatol. 68, 412–420 (2018).
Bazzini, A. A., Lee, M. T. & Giraldez, A. J. Ribosome profiling shows that miR-430 reduces translation before causing mRNA decay in zebrafish. Science 336, 233–237 (2012).
Gumińska, N. et al. Direct profiling of non-adenosines in poly(A) tails of endogenous and therapeutic mRNAs with Ninetails. Nat. Commun. 16, 2664 (2025).
Karikó, K. et al. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 23, 165–175 (2005).
Li, X. et al. Generation of destabilized green fluorescent protein as a transcription reporter. J. Biol. Chem. 273, 34970–34975 (1998).
Xia, X. Detailed dissection and critical evaluation of the Pfizer/BioNTech and Moderna mRNA vaccines. Vaccines (Basel) 9, 734 (2021).
Feshchenko, E. et al. Pandemic influenza vaccine: characterization of A/California/07/2009 (H1N1) recombinant hemagglutinin protein and insights into H1N1 antigen stability. BMC Biotechnol. 12, 77 (2012).
Zhang, H. et al. Algorithm for optimized mRNA design improves stability and immunogenicity. Nature 621, 396–403 (2023).
Enuka, Y. et al. Circular RNAs are long-lived and display only minimal early alterations in response to a growth factor. Nucleic Acids Res. 44, 1370–1383 (2016).
Kristensen, L. S. et al. The biogenesis, biology and characterization of circular RNAs. Nat. Rev. Genet. 20, 675–691 (2019).
Jens, M. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 495, 333–338 (2013).
Chen, R. et al. Engineering circular RNA for enhanced protein production. Nat. Biotechnol. 41, 262–272 (2023).
Lorenz, R. et al. ViennaRNA package 2.0. Algorithms Mol. Biol. 6, 26 (2011).
Huang, L. et al. LinearFold: linear-time approximate RNA folding by 5′-to-3′ dynamic programming and beam search. Bioinformatics 35, i295–i304 (2019).
Seo, J. J., Jung, S.-J., Lee, S., & Kim, V. N. Virus MPRA—primary screen. Zenodo https://doi.org/10.5281/zenodo.14789418 (2025).
Schoenmaker, L. et al. mRNA–lipid nanoparticle COVID-19 vaccines: structure and stability. Int. J. Pharm. 601, 120586 (2021).
Ramanathan, M. et al. RNA–protein interaction detection in living cells. Nat. Methods 15, 207–212 (2018).
Gilbert, L. A. et al. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell 154, 442–451 (2013).
van der Toorn, W. et al. Demultiplexing and barcode-specific adaptive sampling for nanopore direct RNA sequencing. Nat. Commun. 16, 3742 (2025).
Li, H. Minimap2: pairwise alignment for nucleotide sequences. Bioinformatics 34, 3094–3100 (2018).
Jung, S.-J., Seo, J., Lee, S., & Kim, V. N. RNA stability enhancers for durable base-modified mRNA therapeutic. Zenodo https://doi.org/10.5281/zenodo.15041853 (2025).
Lee, S. RNA enhancers for durable base-modified mRNA therapeutics. figshare https://doi.org/10.6084/m9.figshare.29614520.v2 (2025).
Chang, H. ChangLabSNU/Jung-2025-DRS: 09-08-2025 (version 20250908). Zenodo https://doi.org/10.5281/zenodo.17077445 (2025)
